99% of Alzheimer’s Drug Have Failed
Researchers say there’s an urgent need for the development of new Alzheimer’s drugs.
A review at the Cleveland Clinic finds more than 99% of medications developed over the course of a decade have failed.
Now the pipeline for new therapies is nearly dry.
The study says 44-million people around the world suffer from Alzheimer’s and that efforts for drug development need more support.
